Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.2 USD | -0.53% | +8.83% | +175.95% |
May. 09 | Q32 Bio Inc. Provides Corporate Update | CI |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+175.95% | 360M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.41% | 21.6B | |
-12.38% | 22.31B | |
-5.80% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Homology Medicines Doses First Participant in HMI-103 Gene Editing Trial; Expects Initial Data From HMI-103, HMI-203 Trials in 2023